Compound Detail
CHEMBL403989
TG100-801 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12
Basic Information
| ChEMBL ID | CHEMBL403989 |
| Name | TG100-801 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | JMGXJHWTVBGOKG-UHFFFAOYSA-N |
16
Targets
16
Activities
1
Assay Types
20
PK Parameters
20
Publications
1
Known Names
3
Indications
7
Mechanisms
Molecular Properties
580.1
MW (Da)
7.09
ALogP
8
HBA
1
HBD
89.5
PSA (Ų)
0.15
QED
2
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| SRC inhibitor | INHIBITOR | SRC | ✓ | ✓ |
| Ephrin type-B receptor 4 inhibitor | INHIBITOR | Ephrin type-B receptor 4 | ✓ | ✓ |
| Fibroblast growth factor receptor 1 inhibitor | INHIBITOR | Fibroblast growth factor receptor 1 | ✓ | ✓ |
| Fibroblast growth factor receptor 2 inhibitor | INHIBITOR | Fibroblast growth factor receptor 2 | ✓ | ✓ |
| Platelet-derived growth factor receptor beta inhibitor | INHIBITOR | Platelet-derived growth factor receptor beta | ✓ | ✓ |
| Vascular endothelial growth factor receptor 1 inhibitor | INHIBITOR | Vascular endothelial growth factor receptor 1 | ✓ | ✓ |
| Vascular endothelial growth factor receptor 2 inhibitor | INHIBITOR | Vascular endothelial growth factor receptor 2 | ✓ | ✓ |
Indications
Choroidal Neovascularization Macular Degeneration Diabetic Retinopathy
Activity Summary
Kd 16 meas. best 7.19
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Breakpoint cluster region protein CHEMBL5146 | Kd | 7.19 | 7.19 | 65.0 | 1 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | Kd | 6.96 | 6.96 | 109.0 | 1 |
| Receptor-interacting serine/threonine-protein kinase 2 CHEMBL5014 | Kd | 6.72 | 6.72 | 192.0 | 1 |
| Activin receptor type-2B CHEMBL5466 | Kd | 6.38 | 6.38 | 419.0 | 1 |
| TGF-beta receptor type-2 CHEMBL4267 | Kd | 6.15 | 6.15 | 703.0 | 1 |
| Ephrin type-B receptor 4 CHEMBL5147 | Kd | 6.15 | 6.15 | 711.0 | 1 |
| Cyclin-G-associated kinase CHEMBL4355 | Kd | 6.08 | 6.08 | 824.0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | Kd | 5.99 | 5.99 | 1028.0 | 1 |
| Tyrosine-protein kinase ABL2 CHEMBL4014 | Kd | 5.99 | 5.99 | 1034.0 | 1 |
| Ephrin type-A receptor 2 CHEMBL2068 | Kd | 5.92 | 5.92 | 1188.0 | 1 |
| Ephrin type-B receptor 2 CHEMBL3290 | Kd | 5.89 | 5.89 | 1296.0 | 1 |
| Tyrosine-protein kinase Lck CHEMBL258 | Kd | 5.83 | 5.83 | 1466.0 | 1 |
| Epithelial discoidin domain-containing receptor 1 CHEMBL5319 | Kd | 5.76 | 5.76 | 1725.0 | 1 |
| Ephrin type-A receptor 4 CHEMBL3988 | Kd | 5.71 | 5.71 | 1930.0 | 1 |
| Tyrosine-protein kinase Yes CHEMBL2073 | Kd | 5.35 | 5.35 | 4435.0 | 1 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | Kd | 4.97 | 4.97 | 10707.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 63000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 430000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 55000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 35000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 540000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 670000.0 | ng.hr.mL-1 | Mus musculus |
| Cmax | 5300.0 | nM | Mus musculus |
| Cmax | 27000.0 | nM | Mus musculus |
| Cmax | 3700.0 | nM | Mus musculus |
| Cmax | 2400.0 | nM | Mus musculus |
| Cmax | 29000.0 | nM | Mus musculus |
| Cmax | 33000.0 | nM | Mus musculus |
| Cmax | 5.0 | nM | Mus musculus |
| Tmax | 24.0 | hr | Mus musculus |
| Tmax | 24.0 | hr | Mus musculus |
| Tmax | 24.0 | hr | Mus musculus |
| Tmax | 24.0 | hr | Mus musculus |
| Tmax | 24.0 | hr | Mus musculus |
| Tmax | 7.0 | hr | Mus musculus |
| Tmax | 24.0 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18311895 | 10.1021/jm7011276 | Mus musculus | 24 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 11 | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1B | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Actin-related protein 2 | 1 |
| 29191878 | 10.1126/science.aan4368 | Long-chain-fatty-acid--CoA ligase 5 | 1 |
| 29191878 | 10.1126/science.aan4368 | Peroxisomal acyl-coenzyme A oxidase 3 | 1 |
| 29191878 | 10.1126/science.aan4368 | Peroxisomal acyl-coenzyme A oxidase 1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 1 |
| 18311895 | 10.1021/jm7011276 | No relevant target | 1 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 10 | 1 |
| 29191878 | 10.1126/science.aan4368 | Tyrosine-protein kinase ABL2 | 1 |
| 29191878 | 10.1126/science.aan4368 | Tyrosine-protein kinase ABL1 | 1 |
| 29191878 | 10.1126/science.aan4368 | AP2-associated protein kinase 1 | 1 |
| 18311895 | 10.1021/jm7011276 | Tyrosine-protein kinase Yes | 1 |
| 18311895 | 10.1021/jm7011276 | Vascular endothelial growth factor receptor 2 | 1 |
| 18311895 | 10.1021/jm7011276 | Proto-oncogene tyrosine-protein kinase Src | 1 |
Data from ChEMBL 36 via Core Engine